HopeStage
Back to all studies
CompletedNCT05435820

Near-infrared brain laser dosing study for depression

About this titleRead the official source — NCT05435820
Device studyAges 18–75Peru
The study in practice

Understand this study

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.

Listed locations
Lima and 2 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: July 1, 2022
Recruitment status
Completed
Enrollment listed in the registry
50
Sponsor
Peruvian Clinical Research
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
Peru
Age range
From 18 Years to 75 Years
Official registry ID
NCT05435820
Official title
Show the full official title

Near-infrared Transcranial Laser Therapy in Subjects With Major Depressive Disorder: A Study of Dosing With Laser

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Lima

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Peruvian Clinical Research.

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies